Circulating miRNAs in Ageing and Ageing-Related Diseases

Journal of Genetics and Genomics

Volumn 41, Issue 9, 2014, Pages 465-472

  Jung, Hwa Jin ^a   Suh, Yousin ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Ageing; Ageing related disease; Biomarkers; Circulating miRNAs

Indexed keywords

BIOLOGICAL MARKER; CIRCULATING MIRNA; MICRORNA; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; BIOGENESIS; CELL TRANSPORT; DRUG TARGETING; GENE EXPRESSION; HEART DISEASE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; RNA TRANSPORT; SECRETION (PROCESS); VASCULAR DISEASE; ANIMAL; BLOOD; DISEASES; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

AGING; ANIMALS; BIOLOGICAL TRANSPORT; BIOMARKERS; DISEASE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS;

EID: 84908448123     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2014.07.003     Document Type: Review

References (46)

1. Akao Y., Iio A., Itoh T., Noguchi S., Itoh Y., Ohtsuki Y., Naoe T. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 2011, 19:395-399.
2. Alexandrov P.N., Dua P., Hill J.M., Bhattacharjee S., Zhao Y., Lukiw W.J. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 2012, 3:365-373.
3. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 2011, 108:5003-5008.
4. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., Urbanowicz B., Branski P., Ratajczak M.Z., Zembala M. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 2006, 55:808-818.
5. Bonafe M., Barbieri M., Marchegiani F., Olivieri F., Ragno E., Giampieri C., Mugianesi E., Centurelli M., Franceschi C., Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 2003, 88:3299-3304.
6. Cevenini E., Bellavista E., Tieri P., Castellani G., Lescai F., Francesconi M., Mishto M., Santoro A., Valensin S., Salvioli S., Capri M., Zaikin A., Monti D., de Magalhaes J.P., Franceschi C. Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies. Curr. Pharm. Des. 2010, 16:802-813.
7. Chen T.S., Lai R.C., Lee M.M., Choo A.B., Lee C.N., Lim S.K. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010, 38:215-224.
8. Cheng Y., Tan N., Yang J., Liu X., Cao X., He P., Dong X., Qin S., Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond) 2010, 119:87-95.
9. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
10. Collino F., Deregibus M.C., Bruno S., Sterpone L., Aghemo G., Viltono L., Tetta C., Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010, 5:e11803.
11. Cortez M.A., Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9:703-711.
12. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ. Res. 2012, 110:483-495.
13. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P.G., Rubino M., Carena M.C., Spazzafumo L., DeSimone M., Micheli B., Biglioli P., Achilli F., Martelli F., Maggiolini S., Marenzi G., Pompilio G., Capogrossi M.C. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 2010, 31:2765-2773.
14. Dhahbi J.M., Spindler S.R., Atamna H., Yamakawa A., Guerrero N., Boffelli D., Mote P., Martin D.I. Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction. Aging (Albany NY) 2013, 5:130-141.
15. Fabbri M. TLRs as miRNA receptors. Cancer Res. 2012, 72:6333-6337.
16. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Roxe T., Muller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
17. Geekiyanage H., Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 2011, 31:14820-14830.
18. Geekiyanage H., Jicha G.A., Nelson P.T., Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 2012, 235:491-496.
19. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D., Marsh C.B. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3:e3694.
20. Iguchi H., Kosaka N., Ochiya T. Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 2010, 3:478-481.
21. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., Calin G.A., Menard S., Croce C.M. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007, 67:8699-8707.
22. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 2009, 55:1944-1949.
23. Jung H.J., Suh Y. MicroRNA in aging: from discovery to biology. Curr. Genomics 2012, 13:548-557.
24. Karolina D.S., Tavintharan S., Armugam A., Sepramaniam S., Pek S.L., Wong M.T., Lim S.C., Sum C.F., Jeyaseelan K. Circulating miRNA profiles in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 2012, 97:E2271-E2276.
25. Kong L., Zhu J., Han W., Jiang X., Xu M., Zhao Y., Dong Q., Pang Z., Guan Q., Gao L., Zhao J., Zhao L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011, 48:61-69.
26. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
27. Li X., Khanna A., Li N., Wang E. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 2011, 3:985-1002.
28. Llave C., Xie Z., Kasschau K.D., Carrington J.C. Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science 2002, 297:2053-2056.
29. Lukiw W.J., Alexandrov P.N. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol. Neurobiol. 2012, 46:11-19.
30. Norata G.D., Sala F., Catapano A.L., Fernandez-Hernando C. MicroRNAs and lipoproteins: a connection beyond atherosclerosis?. Atherosclerosis 2013, 227:209-215.
31. Noren Hooten N., Fitzpatrick M., Wood W.H., De S., Ejiogu N., Zhang Y., Mattison J.A., Becker K.G., Zonderman A.B., Evans M.K. Age-related changes in microRNA levels in serum. Aging (Albany NY) 2013, 5:725-740.
32. Olivieri F., Antonicelli R., Lorenzi M., D'Alessandra Y., Lazzarini R., Santini G., Spazzafumo L., Lisa R., La Sala L., Galeazzi R., Recchioni R., Testa R., Pompilio G., Capogrossi M.C., Procopio A.D. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int. J. Cardiol. 2013, 167:531-536.
33. Olivieri F., Spazzafumo L., Santini G., Lazzarini R., Albertini M.C., Rippo M.R., Galeazzi R., Abbatecola A.M., Marcheselli F., Monti D., Ostan R., Cevenini E., Antonicelli R., Franceschi C., Procopio A.D. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech. Ageing Dev. 2012, 133:675-685.
34. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
35. Tan L., Yu J.T., Liu Q.Y., Tan M.S., Zhang W., Hu N., Wang Y.L., Sun L., Jiang T., Tan L. Circulating miR-125b as a biomarker of Alzheimer's disease. J. Neurol. Sci. 2014, 336:52-56.
36. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110:13-21.
37. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39:7223-7233.
38. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
39. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13:423-433.
40. Wang G.K., Zhu J.Q., Zhang J.T., Li Q., Li Y., He J., Qin Y.W., Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 2010, 31:659-666.
41. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107:810-817.
42. Zampetaki A., Willeit P., Drozdov I., Kiechl S., Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc. Res. 2012, 93:555-562.
43. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Koppel T., Jahantigh M.N., Lutgens E., Wang S., Olson E.N., Schober A., Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2009, 2:ra81.
44. Zernecke A., Bot I., Djalali-Talab Y., Shagdarsuren E., Bidzhekov K., Meiler S., Krohn R., Schober A., Sperandio M., Soehnlein O., Bornemann J., Tacke F., Biessen E.A., Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 2008, 102:209-217.
45. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Mopps B., Mericskay M., Gierschik P., Biessen E.A., Weber C. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 2005, 96:784-791.
46. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., Sun Q., Wang K., Ba Y., Wang Q., Wang D., Yang J., Liu P., Xu T., Yan Q., Zhang J., Zen K., Zhang C.Y. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.